EPRXNasdaq

EUPRAXIA PHARMACEUTICALS INC.

Pharmaceutical Preparations · A1 · CIK 1581178

Develops extended-release pharmaceutical alternatives for osteoarthritis and eosinophilic esophagitis using proprietary Diffusphere technology

$395M

Market cap

$6.61

Last close

+0.3%

+3.4%

382K

Volume

Price · last 40 sessions-10.9%

May 4L $5.92 · H $7.61Jun 30

Total filings

Jun 22, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance